Bristol Myers Squibb News

AstraZeneca's rumored takeover of Bristol Myers Squibb appears to be off, following reports of preliminary talks and a subsequent denial of ongoing discussions.

AstraZeneca is reportedly in discussions to acquire US rival Bristol Myers Squibb in a deal that could create a pharmaceutical group worth nearly $400bn, making

AstraZeneca is reportedly in talks with Bristol Myers Squibb for a potential $400 billion tie-up. Such a deal would create the world's fourth-largest drugmaker

AstraZeneca Plc reportedly explored an acquisition of Bristol Myers Squibb Co., which would create one of the world's largest pharmaceutical companies, though i